Format

Send to

Choose Destination
N Engl J Med. 2015 Nov 12;373(20):1986-8. doi: 10.1056/NEJMc1505196.

Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.

Author information

1
University of Zurich, Zurich, Switzerland.

Abstract

Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.

PMID:
26559594
PMCID:
PMC4681277
DOI:
10.1056/NEJMc1505196
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center